SC 13D Filing

Company

Cyclerion Therapeutics, Inc.

Filed

October 21, 2022

Accession Number

0000921895-22-002849

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →